Thermon Group Holdings (THR) – Management Comments
-
UPDATE: Oxurion NV Presents Positive Topline Data from Phase 1 Study Evaluating THR-687 for Treatment of DME
-
Thermon Group Holdings (THR) Tops Q2 EPS by 8c, Revenues Beat
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to THR Stock Lookup